MedTrace Logo

Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients

NCT05586646 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-10-19

No results posted yet for this study

Summary

In this clinical trial, we will assess pressure ulcer healing rates in critically ill patients supplemented with IV Alanyl-Glutamine in comparison with critically ill patients not supplemented with alanyl-glutamine.

Conditions

  • Pressure Ulcer

Interventions

DIETARY_SUPPLEMENT

alanyl-glutamine

Amino acid solution for parenteral nutrition containing dipeptide alanyl-glutamine

Sponsors & Collaborators

  • Air Force Specialized Hospital, Cairo, Egypt

    lead OTHER

Principal Investigators

  • Enas Mogawer, Professor · Air Force Specialized Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05586646 on ClinicalTrials.gov